Zobrazeno 1 - 4
of 4
pro vyhledávání: '"I. N. Zaborsky"'
Autor:
A. V. Troianov, I. O. Dementev, I. N. Zaborsky, V. S. Chaykov, O. B. Karyakin, Yu. V. Gumenetskaya
Publikováno v:
Issledovaniâ i Praktika v Medicine, Vol 10, Iss 1, Pp 111-125 (2023)
Purpose of the study. Generalization of the world experience of organ‑preserving treatment in muscle‑invasive bladder cancerMaterials and methods. The literature was searched in Medline, Cochrane Library, Elibrary and PubMed systems. Publications
Externí odkaz:
https://doaj.org/article/e38b07d9e9fa4999ab182ef35c7f00f0
Autor:
A. A. Klimenko, I. P. Kostyuk, O. B. Karyakin, S. A. Moserov, Z. N. Shavladze, I. N. Zaborsky, V. S. Chaykov, M. E. Tarasova
Publikováno v:
Issledovaniâ i Praktika v Medicine, Vol 5, Iss 1, Pp 113-122 (2018)
This article presents a clinical observation of the treatment of recurrent invasive urothelial cancer of the upper urinary tract using surgical and chemotherapy treatments. During the treatment, surgical treatment and 2 chemotherapy lines were perfor
Externí odkaz:
https://doaj.org/article/ba543b37d3e84061aa67f40034fae566
Autor:
D. S. Mikhaylenko, S. A. Sergienko, E. B. Kuznetsova, I. N. Zaborsky, M. I. Martynov, O. B. Loran, G. D. Efremov, S. A. Samoylova, B. Ya. Alekseev, V. V. Musatova, I. V. Bure, M. V. Nemtsova
Publikováno v:
Onkourologiâ, Vol 17, Iss 1, Pp 89-100 (2021)
Background. Bladder cancer (BC) is a common urological cancer, 75 % of which are non-muscle invasive BC. After removal of the primary tumor, the adequate classification of malignancy and the defining of tumor progression risk remains an important iss
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doajarticles::0c03c5b283b62ac145bb1b75ef5e6355
https://oncourology.abvpress.ru/oncur/article/view/1390
https://oncourology.abvpress.ru/oncur/article/view/1390
Autor:
D. S. Mikhaylenko, S. A. Sergienko, I. N. Zaborsky, K. N. Saflullin, S. A. Serebryany, N. Yu. Safronova, M. V. Nemtsova, A. D. Kaprin, B. Ya. Alekseev
Publikováno v:
Onkourologiâ, Vol 14, Iss 4, Pp 124-138 (2019)
Bladder cancer (BC) is represented by non-muscle-invasive forms at the stage Ta, T1, CIS (NMBC) in 75 % of cases. The gold standard of treatment of NMBC patients is transurethral resection, but its implementation does not always allow the patient to
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6f575ebae38d777157db2a6cc0b99831
https://doi.org/10.17650/1726-9776-2018-14-4-124-138
https://doi.org/10.17650/1726-9776-2018-14-4-124-138